沃华医药: 第八届董事会第三次会议决议公告

Core Points - The company held its third meeting of the eighth board on June 27, 2025, with all nine directors present, and the meeting was chaired by Chairman Zhao Bingxian [1][4] - The board approved several resolutions, including strengthening the functions of the audit committee and revising the company's articles of association [1][2] Group 1: Resolutions Passed - The board unanimously approved the proposal to strengthen the audit committee's functions, which will be submitted to the shareholders' meeting for review [1][2] - The board approved the revision of the company's articles of association, with the updated document available for investor review [1][2] - The board approved the revision of the rules for the shareholders' meeting, which will also be submitted for shareholder review [2] - The board approved the revision of the rules for board meetings, with the updated rules published for investor access [2] - The board approved the revision of the audit committee's working rules, which have been reviewed by the audit committee [3] - The board approved the revision of the internal audit management measures, with the updated measures available for investor review [3] - The board agreed to hold the second temporary shareholders' meeting on July 21, 2025, to review the third and fourth proposals [3]